Optimal therapy of tumors requires delivery of sufficient amount of therapeutic agents to the target cancer cells. One of the major restriction of these drugs for cancer therapy is poor transport, which results in low concentrations and a lack of targeting of all cells in a tumor. We present here concepts to analyze and improve antibody penetration in the cancer tIssue.